Biosenic SA (BT1) Stock Price & News

All values in EUR	Sep. 2024	Des. 2024	Mrt. 2025	Jun. 2025
Revenue	-1,30 m	-1,30 m	500,00	500,00
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	341,50 k	341,50 k	14,00 k	14,00 k
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	617,50 k	617,50 k	190,50 k	190,50 k
Operating expense	1,07 m	1,07 m	354,00 k	354,00 k
Total operating expenses	1,07 m	1,07 m	354,00 k	354,00 k
Operating income	-2,37 m	-2,37 m	-353,50 k	-353,50 k
Other non operating income	-731,50 k	-731,50 k	-1,00 k	-1,00 k
EBT including unusual items	-3,53 m	-3,53 m	-356,00 k	-356,00 k
EBT excluding unusual items	-3,53 m	-3,53 m	-356,00 k	-356,00 k
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	114,50 k	114,50 k	-	-
Net income	-2,63 m	-2,63 m	-356,00 k	-356,00 k
Net profit margin	203,05%	203,05%	-71 200,00%	-71 200,00%
Earnings per share	-	-	-	-
Interest and investment income	16,50 k	16,50 k	500,00	500,00
Interest expense	-445,00 k	-445,00 k	-2,00 k	-2,00 k
Net interest expenses	-428,50 k	-428,50 k	-1,50 k	-1,50 k
Depreciation and amortization charges	-	-	149,50 k	149,50 k
EBITDA	-2,28 m	-2,28 m	-280,75 k	-280,75 k
Gain or loss from assets sale	-	-	-	-

Ask anything